{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:33:05Z","timestamp":1785544385934,"version":"3.56.0"},"reference-count":140,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lipidjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.jacl.2015.04.006","type":"journal-article","created":{"date-parts":[[2015,5,2]],"date-time":"2015-05-02T23:24:56Z","timestamp":1430609096000},"page":"S29-S40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"S","title":["Secondary hypertriglyceridemia in children and adolescents"],"prefix":"10.1016","volume":"9","author":[{"given":"Piers R.","family":"Blackett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2815-4816","authenticated-orcid":false,"given":"Don P.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine J.","family":"McNeal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2015.04.006_bib1","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2337\/dc07-1030","article-title":"Prevalence of the metabolic syndrome among U.S. adolescents using the definition from the International Diabetes Federation","volume":"31","author":"Ford","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2015.04.006_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jpeds.2007.06.004","article-title":"Metabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey, 1999-2002","volume":"152","author":"Cook","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.jacl.2015.04.006_bib3","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1161\/01.CIR.0000061521.15730.6E","article-title":"American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood","volume":"107","author":"Kavey","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2015.04.006_bib4","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1177\/0009922811414286","article-title":"Prevalence, characteristics, and risk factors of elevated triglyceride levels in US children","volume":"50","author":"Christian","year":"2011","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.jacl.2015.04.006_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.14423\/SMJ.0000000000000219","article-title":"Pediatric dyslipidemia: recommendations for clinical management","volume":"108","author":"Wilson","year":"2015","journal-title":"South Med J"},{"key":"10.1016\/j.jacl.2015.04.006_bib6","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1111\/j.1651-2227.2010.01920.x","article-title":"Exercise improves the ApoB\/ApoA-I ratio, a marker of the metabolic syndrome in obese children","volume":"99","author":"Ben Ounis","year":"2010","journal-title":"Acta Paediatr"},{"issue":"Suppl 5","key":"10.1016\/j.jacl.2015.04.006_bib7","first-page":"S213","article-title":"Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report","volume":"128","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.jacl.2015.04.006_bib8","first-page":"89","article-title":"A boy with autosomal recessive hypercholesterolaemia","volume":"62","author":"Rodenburg","year":"2004","journal-title":"Neth J Med"},{"key":"10.1016\/j.jacl.2015.04.006_bib9","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM199806043382302","article-title":"Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study","volume":"338","author":"Berenson","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2015.04.006_bib10","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1161\/01.ATV.20.8.1998","article-title":"Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group","volume":"20","author":"McGill","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2015.04.006_bib11","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.106.637793","article-title":"Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies","volume":"115","author":"Sarwar","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2015.04.006_bib12","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"Di Angelantonio","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2015.04.006_bib13","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1542\/peds.2007-1472","article-title":"Usefulness of childhood non-high density lipoprotein cholesterol levels versus other lipoprotein measures in predicting adult subclinical atherosclerosis: the Bogalusa Heart Study","volume":"121","author":"Frontini","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.jacl.2015.04.006_bib14","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1161\/01.ATV.20.3.836","article-title":"Effects of coronary heart disease risk factors on atherosclerosis of selected regions of the aorta and right coronary artery. PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth","volume":"20","author":"McGill","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2015.04.006_bib15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jacl.2012.06.005","article-title":"The interaction of familial and secondary causes of hypertriglyceridemia: role in pancreatitis","volume":"6","author":"Brunzell","year":"2012","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2015.04.006_bib16","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.2337\/diab.46.12.2063","article-title":"Hyperinsulinemia and abdominal obesity affect the expression of hypertriglyceridemia in heterozygous familial lipoprotein lipase deficiency","volume":"46","author":"Julien","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.jacl.2015.04.006_bib17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/MOL.0b013e3283471972","article-title":"Genetic bases of hypertriglyceridemic phenotypes","volume":"22","author":"Johansen","year":"2011","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2015.04.006_bib18","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S2213-8587(13)70191-8","article-title":"The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management","volume":"2","author":"Hegele","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacl.2015.04.006_bib19","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1210\/jc.2008-1270","article-title":"Recognition and management of dyslipidemia in children and adolescents","volume":"93","author":"Kwiterovich","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2015.04.006_bib20","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrendo.2012.15","article-title":"The genetics of familial combined hyperlipidaemia","volume":"8","author":"Brouwers","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jacl.2015.04.006_bib21","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/ng1320","article-title":"Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1)","volume":"36","author":"Pajukanta","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacl.2015.04.006_bib22","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI107332","article-title":"Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia","volume":"52","author":"Goldstein","year":"1973","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2015.04.006_bib23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1307095","article-title":"Loss-of-function mutations in APOC3, triglycerides, and coronary disease","volume":"371","author":"Crosby","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2015.04.006_bib24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1308027","article-title":"Loss-of-function mutations in APOC3 and risk of ischemic vascular disease","volume":"371","author":"Jorgensen","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2015.04.006_bib25","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.placenta.2013.07.063","article-title":"Placental programming of chronic diseases, cancer and lifespan: a review","volume":"34","author":"Barker","year":"2013","journal-title":"Placenta"},{"key":"10.1016\/j.jacl.2015.04.006_bib26","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1530\/EJE-08-0914","article-title":"Small for gestational age status is associated with metabolic syndrome in overweight children","volume":"160","author":"Reinehr","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jacl.2015.04.006_bib27","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/MCO.0b013e328337bbf0","article-title":"Lipid digestion and absorption in early life: an update","volume":"13","author":"Lindquist","year":"2010","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.jacl.2015.04.006_bib28","first-page":"157","article-title":"Current trends and future challenges in neonatal parenteral nutrition","volume":"7","author":"Adamkin","year":"2014","journal-title":"J\u00a0Neonatal\u00a0Perinatal Med"},{"key":"10.1016\/j.jacl.2015.04.006_bib29","first-page":"29","article-title":"Review of macronutrients in parenteral nutrition for neonatal intensive care population","volume":"33","author":"Johnson","year":"2014","journal-title":"Neonatal\u00a0Netw"},{"key":"10.1016\/j.jacl.2015.04.006_bib30","doi-asserted-by":"crossref","first-page":"257168","DOI":"10.4061\/2011\/257168","article-title":"Metabolic syndrome in Italian obese children and adolescents: stronger association with central fat depot than with insulin sensitivity and birth weight","volume":"2011","author":"Brufani","year":"2011","journal-title":"Int J Hypertens"},{"key":"10.1016\/j.jacl.2015.04.006_bib31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2337\/diacare.29.01.06.dc05-0952","article-title":"Racial differences in adiponectin in youth: relationship to visceral fat and insulin sensitivity","volume":"29","author":"Lee","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2015.04.006_bib32","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1210\/jc.2013-4398","article-title":"Relationships between 24-hour urinary free cortisol concentrations and metabolic syndrome in obese children","volume":"99","author":"Reinehr","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2015.04.006_bib33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40618-013-0014-0","article-title":"Correlation between cortisol and components of the metabolic syndrome in obese children and adolescents","volume":"37","author":"Guzzetti","year":"2014","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jacl.2015.04.006_bib34","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1590\/1806-9282.60.01.017","article-title":"Cortisol: the villain in metabolic syndrome?","volume":"60","author":"Paredes","year":"2014","journal-title":"Rev Assoc Med Bras"},{"key":"10.1016\/j.jacl.2015.04.006_bib35","doi-asserted-by":"crossref","first-page":"427640","DOI":"10.1155\/2013\/427640","article-title":"Chronic inhibition of 11 beta -hydroxysteroid dehydrogenase type 1 activity decreases hypertension, insulin resistance, and hypertriglyceridemia in metabolic syndrome","volume":"2013","author":"Schnackenberg","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jacl.2015.04.006_bib36","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.2337\/diabetes.50.11.2444","article-title":"Longitudinal study on pubertal insulin resistance","volume":"50","author":"Goran","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.jacl.2015.04.006_bib37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1210\/jc.2010-1642","article-title":"Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline","volume":"96","author":"Copeland","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2015.04.006_bib38","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.2337\/dc10-2234","article-title":"The triglyceride-to-HDL cholesterol ratio: association with insulin resistance in obese youths of different ethnic backgrounds","volume":"34","author":"Giannini","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2015.04.006_bib39","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0002-9343(74)90006-0","article-title":"Reappraisal of the role of insulin in hypertriglyceridemia","volume":"57","author":"Olefsky","year":"1974","journal-title":"Am J Med"},{"key":"10.1016\/j.jacl.2015.04.006_bib40","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1089\/met.2011.0021","article-title":"Genetic associations with metabolic syndrome and its quantitative traits by race\/ethnicity in the United States","volume":"9","author":"Vassy","year":"2011","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.jacl.2015.04.006_bib41","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1210\/jc.2009-1301","article-title":"Waist circumference, atherogenic lipoproteins, and vascular smooth muscle biomarkers in children","volume":"94","author":"Burns","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2015.04.006_bib42","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jpeds.2006.08.075","article-title":"Waist circumference, blood pressure, and lipid components of the metabolic syndrome","volume":"149","author":"Lee","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.jacl.2015.04.006_bib43","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2337\/diacare.25.6.1009","article-title":"Association of acanthosis nigricans with hyperinsulinemia compared with other selected risk factors for type 2 diabetes in Cherokee Indians: the Cherokee Diabetes Study","volume":"25","author":"Stoddart","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2015.04.006_bib44","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2337\/diab.46.6.983","article-title":"Skeletal muscle triglyceride levels are inversely related to insulin action","volume":"46","author":"Pan","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.jacl.2015.04.006_bib45","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0026-0495(81)90167-0","article-title":"Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics, and plasma triglyceride levels in normotriglyceridemic man","volume":"30","author":"Tobey","year":"1981","journal-title":"Metabolism"},{"key":"10.1016\/j.jacl.2015.04.006_bib46","doi-asserted-by":"crossref","first-page":"E1000","DOI":"10.1152\/ajpendo.2001.280.6.E1000","article-title":"Systemic and regional free fatty acid metabolism in type 2 diabetes","volume":"280","author":"Basu","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jacl.2015.04.006_bib47","doi-asserted-by":"crossref","first-page":"19362","DOI":"10.1074\/jbc.M400220200","article-title":"Regulation of hepatic apolipoprotein B-lipoprotein assembly and secretion by the availability of fatty acids. I. Differential response to the delivery of fatty acids via albumin or remnant-like emulsion particles","volume":"279","author":"Zhang","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2015.04.006_bib48","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/ATVBAHA.111.242073","article-title":"Absence of acute inhibitory effect of insulin on chylomicron production in type 2 diabetes","volume":"32","author":"Nogueira","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2015.04.006_bib49","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jacl.2012.06.007","article-title":"Apolipoproteins A-I, B, and C-III in young adult Cherokee with metabolic syndrome with or without type 2 diabetes","volume":"7","author":"Wang","year":"2013","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2015.04.006_bib50","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.clinbiochem.2012.02.005","article-title":"HOMA-IR and non-HDL-C as predictors of high cholesteryl ester transfer protein activity in patients at risk for type 2 diabetes","volume":"45","author":"Coniglio","year":"2012","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jacl.2015.04.006_bib51","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1194\/jlr.R200017-JLR200","article-title":"Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet","volume":"44","author":"Deeb","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2015.04.006_bib52","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","article-title":"Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management","volume":"32","author":"Chapman","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2015.04.006_bib53","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1161\/01.CIR.0000035280.64322.31","article-title":"New perspectives on atherogenesis: role of abnormal triglyceride-rich lipoprotein metabolism","volume":"106","author":"Ginsberg","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2015.04.006_bib54","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2337\/diacare.3.2.301","article-title":"Treatment of juvenile-onset diabetes by subcutaneous infusion of insulin with a portable pump","volume":"3","author":"Sherwin","year":"1980","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2015.04.006_bib55","doi-asserted-by":"crossref","first-page":"426","DOI":"10.7326\/0003-4819-95-4-426","article-title":"Plasma lipid and lipoprotein levels with continuous subcutaneous insulin infusion in type I diabetes mellitus","volume":"95","author":"Dunn","year":"1981","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacl.2015.04.006_bib56","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00000441-198605000-00010","article-title":"Plasma lipids and apolipoproteins in a 13-year-old boy with diabetic ketoacidosis and extreme hyperlipidemia","volume":"291","author":"Blackett","year":"1986","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jacl.2015.04.006_bib57","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0022-2275(20)38186-4","article-title":"Effects of insulin on plasma lipoproteins in diabetic ketoacidosis: evidence for a change in high density lipoprotein composition during treatment","volume":"23","author":"Weidman","year":"1982","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2015.04.006_bib58","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/00007611-198506000-00004","article-title":"Increased levels of HDL-cholesterol and apolipoprotein A-I after intensified insulin therapy for diabetes","volume":"78","author":"Wilson","year":"1985","journal-title":"South Med J"},{"key":"10.1016\/j.jacl.2015.04.006_bib59","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jama.2014.16327","article-title":"Mortality in type 1 diabetes in the current era: two steps forward, one step backward","volume":"313","author":"Katz","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2015.04.006_bib60","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1007\/s00125-010-1860-3","article-title":"In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study","volume":"53","author":"Orchard","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacl.2015.04.006_bib61","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1203\/00006450-200111000-00013","article-title":"Postprandial chylomicron clearance rate in late teenagers with diabetes mellitus type 1","volume":"50","author":"Van Waarde","year":"2001","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jacl.2015.04.006_bib62","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1464-5491.2010.03138.x","article-title":"Increased risk of cardiovascular disease in type 1 diabetes: arterial exposure to remnant lipoproteins leads to enhanced deposition of cholesterol and binding to glycated extracellular matrix proteoglycans","volume":"28","author":"Mangat","year":"2011","journal-title":"Diabet Med"},{"key":"10.1016\/j.jacl.2015.04.006_bib63","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF00405084","article-title":"Postprandial triglyceride response in type 1 (insulin-dependent) diabetes mellitus is not altered by short-term deterioration in glycaemic control or level of postprandial insulin replacement","volume":"34","author":"Lewis","year":"1991","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacl.2015.04.006_bib64","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1042\/CS20070308","article-title":"Apolipoprotein C-III: understanding an emerging cardiovascular risk factor","volume":"114","author":"Ooi","year":"2008","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jacl.2015.04.006_bib65","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/ATVBAHA.110.220723","article-title":"Transcriptional activation of apolipoprotein CIII expression by glucose may contribute to diabetic dyslipidemia","volume":"31","author":"Caron","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2015.04.006_bib66","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1172\/JCI200419992","article-title":"Foxo1 mediates insulin action on apoC-III and triglyceride metabolism","volume":"114","author":"Altomonte","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2015.04.006_bib67","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00007611-198804000-00015","article-title":"Plasma apolipoprotein C-III levels in children with type I diabetes","volume":"81","author":"Blackett","year":"1988","journal-title":"South Med J"},{"key":"10.1016\/j.jacl.2015.04.006_bib68","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1542\/peds.89.5.936","article-title":"Apolipoprotein A-I, A-II, B, C-II, and C-III in children with insulin-dependent diabetes mellitus","volume":"89","author":"al Muhtaseb","year":"1992","journal-title":"Pediatrics"},{"key":"10.1016\/j.jacl.2015.04.006_bib69","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1751-7176.2010.00395.x","article-title":"Impact of type 1 diabetes and body weight status on cardiovascular risk factors in adolescent children","volume":"13","author":"Krishnan","year":"2011","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jacl.2015.04.006_bib70","first-page":"18","article-title":"Apolipoprotein C-III protein concentrations and gene polymorphisms in Type 1 diabetes: associations with microvascular disease complications in the DCCT\/EDIC cohort","volume":"19","author":"Klein","year":"2005","journal-title":"J\u00a0Diabetes\u00a0Complications"},{"key":"10.1016\/j.jacl.2015.04.006_bib71","first-page":"447","article-title":"Apolipoprotein-defined lipoproteins and apolipoproteins: associations with abnormal albuminuria in type 1 diabetes in the diabetes control and complications trial\/epidemiology of diabetes interventions and complications cohort","volume":"27","author":"Jenkins","year":"2013","journal-title":"J\u00a0Diabetes\u00a0Complications"},{"key":"10.1016\/j.jacl.2015.04.006_bib72","article-title":"Modified lipoproteins in diabetic retinopathy: a local action in the retina","volume":"4","author":"Yu","year":"2013","journal-title":"J Clin Exp Ophthalmol"},{"issue":"Suppl 1","key":"10.1016\/j.jacl.2015.04.006_bib73","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000178028","article-title":"Ectopic fat deposition and the metabolic syndrome in obese children and adolescents","volume":"71","author":"Cali","year":"2009","journal-title":"Horm Res"},{"key":"10.1016\/j.jacl.2015.04.006_bib74","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1053\/j.gastro.2003.11.020","article-title":"Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease","volume":"126","author":"Lonardo","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacl.2015.04.006_bib75","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/hep.25631","article-title":"Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific manner","volume":"56","author":"Clark","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jacl.2015.04.006_bib76","doi-asserted-by":"crossref","first-page":"39802","DOI":"10.1074\/jbc.M510391200","article-title":"Hepatitis C virus nonstructural proteins inhibit apolipoprotein B100 secretion","volume":"280","author":"Domitrovich","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2015.04.006_bib77","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1053\/j.jrn.2004.10.003","article-title":"Dyslipidemia and nephrotic syndrome: recent advances","volume":"15","author":"Kronenberg","year":"2005","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.jacl.2015.04.006_bib78","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1523-1755.1998.00831.x","article-title":"Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis","volume":"53","author":"de Sain-van der Velden","year":"1998","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"10.1016\/j.jacl.2015.04.006_bib79","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000168197","article-title":"Pathogenesis of hyperlipidemia in the nephrotic syndrome","volume":"10","author":"Attman","year":"1990","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jacl.2015.04.006_bib80","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00467-007-0467-5","article-title":"Lipoprotein metabolism in chronic renal insufficiency","volume":"22","author":"Saland","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jacl.2015.04.006_bib81","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/10507250252949405","article-title":"Thyroid disease and lipids","volume":"12","author":"Duntas","year":"2002","journal-title":"Thyroid"},{"key":"10.1016\/j.jacl.2015.04.006_bib82","first-page":"1049","article-title":"Subclinical hypothyroidism in childhood and adolescence","volume":"27","author":"Catli","year":"2014","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jacl.2015.04.006_bib83","doi-asserted-by":"crossref","first-page":"6983","DOI":"10.1073\/pnas.89.15.6983","article-title":"Importance of growth hormone for the induction of hepatic low density lipoprotein receptors","volume":"89","author":"Rudling","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacl.2015.04.006_bib84","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1210\/jcem.84.11.6088","article-title":"The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board","volume":"84","author":"Bengtsson","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2015.04.006_bib85","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00041433-199405030-00002","article-title":"Growth hormone and hepatic lipoprotein metabolism","volume":"5","author":"Angelin","year":"1994","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2015.04.006_bib86","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1210\/endo.131.6.1446613","article-title":"In\u00a0vivo growth hormone treatment stimulates secretion of very low density lipoprotein by the isolated perfused rat liver","volume":"131","author":"Elam","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.jacl.2015.04.006_bib87","first-page":"1423","article-title":"The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B","volume":"76","author":"Feingold","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2015.04.006_bib88","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1468-1293.2007.00470.x","article-title":"Longitudinal changes in serum lipids among HIV-infected men on highly active antiretroviral therapy","volume":"8","author":"Riddler","year":"2007","journal-title":"HIV Med"},{"key":"10.1016\/j.jacl.2015.04.006_bib89","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0021-9150(77)90141-1","article-title":"Inhibition of lipoprotein lipase activity by a monoclonal immunoglobulin in autoimmune hyperlipidemia","volume":"26","author":"Beaumont","year":"1977","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2015.04.006_bib90","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2169\/internalmedicine.36.920","article-title":"Autoimmune hyperlipidemia with inhibitory monoclonal antibodies against low density lipoprotein binding to fibroblasts in a case with multiple myeloma","volume":"36","author":"Nozaki","year":"1997","journal-title":"Intern Med"},{"key":"10.1016\/j.jacl.2015.04.006_bib91","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1309\/AJCP2JBDEELPA7HT","article-title":"Evaluation of monoclonal and oligoclonal gammopathies in a pediatric population in a major urban center","volume":"141","author":"Karafin","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jacl.2015.04.006_bib92","first-page":"505","article-title":"Adverse effects of corticosteroids on the cardiovascular system","volume":"16","author":"Sholter","year":"2000","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacl.2015.04.006_bib93","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00296-014-3194-9","article-title":"Glucocorticoid use is associated with increase in HDL and no change in other lipids in rheumatoid arthritis patients","volume":"35","author":"Schroeder","year":"2015","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jacl.2015.04.006_bib94","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1016\/j.ejca.2014.06.023","article-title":"Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia","volume":"50","author":"Bhojwani","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jacl.2015.04.006_bib95","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1210\/jc.2009-2480","article-title":"Changes in apolipoprotein B100-containing lipoprotein metabolism due to an estrogen plus progestin oral contraceptive: a stable isotope kinetic study","volume":"95","author":"Duvillard","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2015.04.006_bib96","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.contraception.2004.08.002","article-title":"Evaluation of lipid profile in adolescents during long-term use of combined oral hormonal contraceptives","volume":"71","author":"Guazzelli","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.jacl.2015.04.006_bib97","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.contraception.2011.09.014","article-title":"The effect of obesity and low-dose oral contraceptives on carbohydrate and lipid metabolism","volume":"85","author":"Beasley","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.jacl.2015.04.006_bib98","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/0003-4819-128-6-199803150-00008","article-title":"Epidemiology of oral contraceptives and cardiovascular disease","volume":"128","author":"Chasan-Taber","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacl.2015.04.006_bib99","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/archderm.142.8.1016","article-title":"A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris","volume":"142","author":"Zane","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jacl.2015.04.006_bib100","first-page":"1855","article-title":"Marked hyperlipidemia and pancreatitis associated with isotretinoin therapy","volume":"87","author":"McCarter","year":"1992","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jacl.2015.04.006_bib101","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/S0006-2952(01)00803-6","article-title":"Retinoid X receptor agonist elevation of serum triglycerides in rats by potentiation of retinoic acid receptor agonist induction or by action as single agents","volume":"62","author":"Standeven","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jacl.2015.04.006_bib102","doi-asserted-by":"crossref","first-page":"7305","DOI":"10.1038\/sj.onc.1206936","article-title":"Retinoids in cancer therapy and chemoprevention: promise meets resistance","volume":"22","author":"Freemantle","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.jacl.2015.04.006_bib103","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1097\/00007890-199405270-00014","article-title":"Relation of cyclosporine blood levels to adverse effects on lipoproteins","volume":"57","author":"Kuster","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.jacl.2015.04.006_bib104","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/petr.12007","article-title":"Lipid metabolism and oxidative stress in children after liver transplantation treated with sirolimus","volume":"16","author":"Jankowska","year":"2012","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jacl.2015.04.006_bib105","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1001\/jama.1989.03430010065032","article-title":"Effects of cyclosporine therapy on plasma lipoprotein levels","volume":"262","author":"Ballantyne","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2015.04.006_bib106","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/01.tp.0000235446.50715.ef","article-title":"Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantation","volume":"82","author":"Wissing","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.jacl.2015.04.006_bib107","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0022-3565(24)39134-7","article-title":"Effect of cyclosporine on HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, HDL receptor, VLDL receptor, and lipoprotein lipase expressions","volume":"294","author":"Vaziri","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jacl.2015.04.006_bib108","doi-asserted-by":"crossref","first-page":"17427","DOI":"10.7448\/IAS.15.2.17427","article-title":"Lipodystrophy among HIV-infected children and adolescents on highly active antiretroviral therapy in Uganda: a cross sectional study","volume":"15","author":"Piloya","year":"2012","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.jacl.2015.04.006_bib109","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/archinte.160.13.2050","article-title":"Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study","volume":"160","author":"Tsiodras","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacl.2015.04.006_bib110","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1468-1293.2005.00325.x","article-title":"Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone","volume":"6","author":"Jones","year":"2005","journal-title":"HIV Med"},{"key":"10.1016\/j.jacl.2015.04.006_bib111","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0002-9343(87)90692-9","article-title":"Hypertriglyceridemia: a contraindication to the use of bile acid binding resins","volume":"83","author":"Crouse","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.jacl.2015.04.006_bib112","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2015.04.006_bib113","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1542\/peds.114.2.S2.555","article-title":"The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents","volume":"114","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.jacl.2015.04.006_bib114","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.amjmed.2014.07.026","article-title":"Dyslipidemia patterns among Hispanics\/Latinos of diverse background in the United States","volume":"127","author":"Rodriguez","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.jacl.2015.04.006_bib115","doi-asserted-by":"crossref","DOI":"10.1007\/s00535-015-1058-z","article-title":"Biphasic effect of alcohol intake on the development of fatty liver disease","author":"Takahashi","year":"2015","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jacl.2015.04.006_bib116","first-page":"9055","article-title":"Nonalcoholic fatty liver disease and the heart in children and adolescents","volume":"20","author":"Pacifico","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jacl.2015.04.006_bib117","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jacl.2012.08.005","article-title":"Glycogen storage disease type Ia: linkage of glucose, glycogen, lactic acid, triglyceride, and uric acid metabolism","volume":"6","author":"Sever","year":"2012","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2015.04.006_bib118","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1203\/00006450-198904000-00002","article-title":"Gastric drip feeding in patients with glycogen storage disease type I: its effects on growth and plasma lipids and apolipoproteins","volume":"25","author":"Fernandes","year":"1989","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jacl.2015.04.006_bib119","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S1043-2760(03)00078-X","article-title":"Congenital generalized lipodystrophy: significance of triglyceride biosynthetic pathways","volume":"14","author":"Agarwal","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jacl.2015.04.006_bib120","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/jhn.12030","article-title":"Effect of dietary interventions in the maintenance of normoglycaemia in glycogen storage disease type 1A: a systematic review and meta-analysis","volume":"26","author":"Shah","year":"2013","journal-title":"J Hum Nutr Diet"},{"key":"10.1016\/j.jacl.2015.04.006_bib121","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/jc.2011-1159","article-title":"Clinical review#: lipodystrophies: genetic and acquired body fat disorders","volume":"96","author":"Garg","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2015.04.006_bib122","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1530\/EJE-09-1027","article-title":"Resistance to leptin-replacement therapy in Berardinelli-Seip congenital lipodystrophy: an immunological origin","volume":"162","author":"Beltrand","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jacl.2015.04.006_bib123","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jacl.2012.11.006","article-title":"Lipoprotein abnormalities in compound heterozygous lipoprotein lipase deficiency after treatment with a low-fat diet and orlistat","volume":"7","author":"Blackett","year":"2013","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2015.04.006_bib124","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.2165\/00003495-200666120-00012","article-title":"Orlistat: a review of its use in the management of obesity","volume":"66","author":"Henness","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.jacl.2015.04.006_bib125","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ypmed.2013.08.010","article-title":"An overview of national clinical guidelines for the management of childhood obesity in primary care","volume":"57","author":"Richardson","year":"2013","journal-title":"Prev Med"},{"key":"10.1016\/j.jacl.2015.04.006_bib126","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1001\/jama.297.24.2697","article-title":"Effects of a weight management program on body composition and metabolic parameters in overweight children: a randomized controlled trial","volume":"297","author":"Savoye","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2015.04.006_bib127","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.2337\/dc09-0738","article-title":"Statin therapy and risk of developing type 2 diabetes: a meta-analysis","volume":"32","author":"Rajpathak","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2015.04.006_bib128","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4140\/TCP.n.2014.317","article-title":"Statin-associated incident diabetes: a literature review","volume":"29","author":"Park","year":"2014","journal-title":"Consult Pharm"},{"key":"10.1016\/j.jacl.2015.04.006_bib129","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1161\/01.CIR.102.16.1886","article-title":"VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial","volume":"102","author":"Sacks","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2015.04.006_bib130","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0140-6736(10)60545-4","article-title":"Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2015.04.006_bib131","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/adc.60.1.34","article-title":"Double blind trial of bezafibrate in familial hypercholesterolaemia","volume":"60","author":"Wheeler","year":"1985","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jacl.2015.04.006_bib132","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1542\/peds.92.1.78","article-title":"Niacin treatment of hypercholesterolemia in children","volume":"92","author":"Colletti","year":"1993","journal-title":"Pediatrics"},{"key":"10.1016\/j.jacl.2015.04.006_bib133","doi-asserted-by":"crossref","first-page":"71i","DOI":"10.1016\/j.amjcard.2005.12.029","article-title":"Clinical overview of Omacor: a concentrated formulation of omega-3 polyunsaturated fatty acids","volume":"98","author":"Bays","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2015.04.006_bib134","doi-asserted-by":"crossref","first-page":"1645S","DOI":"10.1093\/ajcn\/65.5.1645S","article-title":"n-3 fatty acids and serum lipoproteins: human studies","volume":"65","author":"Harris","year":"1997","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jacl.2015.04.006_bib135","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1089\/jmf.2008.1250","article-title":"Dose-response of n-3 polyunsaturated fatty acids on lipid profile and tolerability in mildly hypertriglyceridemic subjects","volume":"12","author":"Park","year":"2009","journal-title":"J Med Food"},{"key":"10.1016\/j.jacl.2015.04.006_bib136","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/07315724.1991.10718148","article-title":"Effects of four doses of n-3 fatty acids given to hyperlipidemic patients for six months","volume":"10","author":"Harris","year":"1991","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.jacl.2015.04.006_bib137","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/0009922814527503","article-title":"Effectiveness of omega-3 polysaturated fatty acids (fish oil) supplementation for treating hypertriglyceridemia in children and adolescents","volume":"53","author":"Chahal","year":"2014","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.jacl.2015.04.006_bib138","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jacl.2012.07.001","article-title":"Icosapent ethyl, a pure EPA omega-3 fatty acid: effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study)","volume":"6","author":"Bays","year":"2012","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2015.04.006_bib139","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jacl.2013.10.003","article-title":"Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: the EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial","volume":"8","author":"Kastelein","year":"2014","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2015.04.006_bib140","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF02529870","article-title":"n-3 fatty acids and lipoproteins: comparison of results from human and animal studies","volume":"31","author":"Harris","year":"1996","journal-title":"Lipids"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287415002081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287415002081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T19:47:42Z","timestamp":1748375262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287415002081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":140,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1933287415002081"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2015.04.006","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secondary hypertriglyceridemia in children and adolescents","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2015.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 National Lipid Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}